Eamon Ellwood
About
In The Last Decade
Eamon Ellwood
16 papers receiving 510 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Physiology 336
- Pulmonary and Respiratory Medicine 192
- Immunology and Allergy 159
- Dermatology 88
- Health, Toxicology and Mutagenesis 57
Countries citing papers authored by Eamon Ellwood
This map shows the geographic impact of Eamon Ellwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eamon Ellwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eamon Ellwood more than expected).
Fields of papers citing papers by Eamon Ellwood
This network shows the impact of papers produced by Eamon Ellwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eamon Ellwood. The network helps show where Eamon Ellwood may publish in the future.
Co-authorship network of co-authors of Eamon Ellwood
This figure shows the co-authorship network connecting the top 25 collaborators of Eamon Ellwood. A scholar is included among the top collaborators of Eamon Ellwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eamon Ellwood. Eamon Ellwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study breakdown → | 127 |
| 3 | 88 | |
| 4 | Asthma Network. | 1 |
| 5 | COVID-19 and Asthma. | 2 |
| 6 | 3 | |
| 7 | 35 | |
| 8 | 34 | |
| 9 | 11 | |
| 10 | 26 | |
| 11 | 121 | |
| 12 | [Accepted Manuscript] The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors. | 1 |
| 13 | 1 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.